Evidence map›Paper›PMID 36133863›Full record

ArticleNanoscale advances2020

Nanonewton forces between

Marion Mathelié-Guinlet, Felipe Viela, Giampiero Pietrocola, Pietro Speziale, Yves F Dufrêne

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Hemoglobin receptor redundancy inJournal of structural biology: X · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Marion Mathelié-GuinletLouvain Institute of Biomolecular Science and Technology, UCLouvain Croix du Sud, 4-5, bte L7.07.07 B-1348 Louvain-la-Neuve Belgium yves.dufrene@uclouvain.be.ORCID https://orcid.org/0000-0001-9023-3470
Felipe VielaLouvain Institute of Biomolecular Science and Technology, UCLouvain Croix du Sud, 4-5, bte L7.07.07 B-1348 Louvain-la-Neuve Belgium yves.dufrene@uclouvain.be.ORCID https://orcid.org/0000-0003-0566-9291
Giampiero PietrocolaDepartment of Molecular Medicine, Unit of Biochemistry, University of Pavia Viale Taramelli 3/b 27100 Pavia Italy pietro.speziale@unipv.it.ORCID https://orcid.org/0000-0002-7069-8155
Pietro SpezialeDepartment of Molecular Medicine, Unit of Biochemistry, University of Pavia Viale Taramelli 3/b 27100 Pavia Italy pietro.speziale@unipv.it.ORCID https://orcid.org/0000-0002-6087-1604
Yves F DufrêneLouvain Institute of Biomolecular Science and Technology, UCLouvain Croix du Sud, 4-5, bte L7.07.07 B-1348 Louvain-la-Neuve Belgium yves.dufrene@uclouvain.be.ORCID https://orcid.org/0000-0002-7289-4248
PRG S&Tech (South Korea)University of Pavia · ITWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-molecule experiments have recently revealed that the interaction between staphylococcal surface proteins and their ligands can be extremely strong, equivalent to the strength of covalent bonds. Here, we report on the unusually high binding strength between

Identifiers

PMID36133863
PMCPMC9419033
OpenAlexW3097582901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.